Back to Search

DAVID MEDINA, M.D.

M.D.

Vascular & Interventional Radiology Physician

NPI: 1093764722Individual

Specialties, Licenses & Credentials

Body Imaging Physician

Radiology — Body Imaging

Code: 2085B0100X

21441(AZ)
Pediatric Radiology Physician

Radiology — Pediatric Radiology

Code: 2085P0229X

21441(AZ)
Diagnostic Radiology Physician

Radiology — Diagnostic Radiology

Code: 2085R0202X

21441(AZ)
Therapeutic Radiology Physician

Radiology — Therapeutic Radiology

Code: 2085R0203X

21441(AZ)
Diagnostic Ultrasound Physician

Radiology — Diagnostic Ultrasound

Code: 2085U0001X

21441(AZ)
Vascular & Interventional Radiology PhysicianPrimary

Radiology — Vascular & Interventional Radiology

Code: 2085R0204X

21441(AZ)

Research & Publications (20)

Premalignant and malignant mammary lesions induced by MMTV and chemical carcinogens.
PMID 18663563·J Mammary Gland Biol Neoplasia·2008
6-review
Inhibition of mammary tumorigenesis by estrogen and progesterone in genetically engineered mice.
PMID 18540570·Ernst Schering Found Symp Proc·2007
6-review
Mammary developmental fate and breast cancer risk.
PMID 16172188·Endocr Relat Cancer·2005
6-review
p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis.
PMID 14559792·Cancer Res·2003
7-preclinical
Biological and molecular characteristics of the premalignant mouse mammary gland.
PMID 12242106·Biochim Biophys Acta·2002
4-observational
Short-term exposure to estrogen and progesterone induces partial protection against N-nitroso-N-methylurea-induced mammary tumorigenesis in Wistar--Furth rats.
PMID 11410318·Cancer Lett·2001
7-preclinical
Molecular studies in the GJB2 gene (Cx26) among a deaf population from Bogotá, Colombia: results of a screening program.
PMID 19027181·Int J Pediatr Otorhinolaryngol·2009
4-observational
Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinoma.
PMID 19174488·Clin Cancer Res·2009
7-preclinical
Identification of modulated genes by three classes of chemopreventive agents at preneoplastic stages in a p53-null mouse mammary tumor model.
PMID 19174580·Cancer Prev Res (Phila)·2009
7-preclinical
Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib.
PMID 19174577·Cancer Prev Res (Phila)·2009
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
9323 E BAHIA DRIVE STE 200
SCOTTSDALE, AZ 85260

Quick Facts

NPI
1093764722
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
6
Locations
1
Publications
20

Are you this provider?

Claim Your Profile